Page last updated: 2024-11-05

ticlopidine and Cholangiocarcinoma

ticlopidine has been researched along with Cholangiocarcinoma in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujikawa, T1
Tanaka, A1

Other Studies

1 other study available for ticlopidine and Cholangiocarcinoma

ArticleYear
Successful multidisciplinary treatment of hilar cholangiocarcinoma in a patient with complicated new-onset coronary artery disease.
    BMJ case reports, 2014, Apr-23, Volume: 2014

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bile Duct Neoplasms; Bile Ducts, Intr

2014